The modification of the extended 1 → 3 anthraquinonoid monomer 1 by substitution of the central aliphatic moiety with a more rigid, aromatic moiety has allowed the syntheses of the new branched building block 6 possessing multiple, internal redox sites. This monomer was used to generate the first tier, dendritic macromolecules 8 and 9, which incorporate different internal redox centers within the infrastructure as well as the traditional peripheral multifunctionality. Using cyclic voltammetry experiments, the electrochemical response and electronic interactions between the two electroactive sites (the anthraquinonoid and nitroaromatic moieties) of these dendritic constructs were explored.
Newkome, George R.,Narayanan, Venkatraj V.,Godinez, Luis A.
Iron binding dendrimers: A novel approach for the treatment of haemochromatosis
A range of iron binding dendrimers terminated with hexadentate ligands formed from hydroxypyridinone, hydroxypyranone, and catechol moieties have been synthesized in order to investigate their potential as clinically useful iron(III)-selective chelators capable of removing dietary iron from the gastrointestinal tract and preventing the development of iron overload typical of haemochromatosis and thalassaemia intermedia. The iron chelating abilities of these molecules have been characterized by MALDI-TOF mass spectrometry and UV spectrometry. Hydroxypyridinone-terminated dendrimers were found to possess a high affinity and selectivity for iron(III). A hydroxypyridinone-based dendrimer was demonstrated to be highly efficient at reducing the absorption of iron(III) in rat intestine. This family of dendrimers may find an application in the treatment of iron overload.
Zhou, Tao,Neubert, Hendrik,Liu, Ding Yong,Liu, Zu Dong,Ma, Yong Min,Kong, Xiao Le,Luo, Wei,Mark, Sykes,Hider, Robert C.
p. 4171 - 4182
(2007/10/03)
More Articles about upstream products of 263843-49-8
Get Best Price for263843-49-84-{3-[3-tert-butoxycarbonyl-1,1-bis-(2-tert-butoxycarbonyl-ethyl)-propylcarbamoyl]-5-nitro-benzoylamino}-4-(2-tert-butoxycarbonyl-ethyl)-heptanedioic acid di-tert-butyl ester